Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Apr 1, 2015
Insider Transaction Report
Form 4
YORDON JEFFREY
DirectorChief Executive Officer
Transactions
- Gift
Common Stock
2015-02-27−48,850→ 616,076 total
Holdings
- 48,850(indirect: See Footnote)
Common Stock
- 21,088(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares held by a member of Mr. Yordon's immediate family sharing the same household.